Estados financieros detallados de Atossa Therapeutics, Inc. (ATOS): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $303482 | $128994 | $44197 | $52789 | $46600 | $23000 | $8000 | $23000 | $17000 | 0 |
| Beneficio Bruto | -$303482 | -$128994 | -$44197 | -$52789 | -$46600 | -$23000 | -$8000 | -$23000 | -$17000 | 0 |
| I+D | $770427 | $2.3M | $4.2M | $7.1M | $6.6M | $9.2M | $15.1M | $17.3M | $14.1M | $21.2M |
| Generales y Administrativos | $6.5M | $4.9M | $7.2M | $10.6M | $8.0M | $11.3M | $12.6M | $14.0M | $13.5M | $16.0M |
| Gastos Operativos | $6.9M | $7.1M | $11.4M | $17.3M | $14.6M | $20.5M | $27.7M | $31.4M | $27.6M | $37.1M |
| Beneficio Operativo | -$7.2M | -$7.2M | -$11.4M | -$17.3M | -$14.6M | -$20.5M | -$27.7M | -$31.4M | -$27.6M | -$37.1M |
| EBITDA | -$6.1M | -$7.8M | -$11.4M | -$17.2M | -$14.6M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| Gastos por Intereses | 0 | $192817 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$6.4M | -$8.1M | -$11.4M | -$17.2M | -$17.8M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| Impuestos | 0 | 0 | -$29299 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$6.4M | -$8.1M | -$11.4M | -$17.2M | -$17.8M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| BPA | $-388.95 | $-164.55 | $-82.50 | $-30.45 | $-29.55 | $-2.70 | $-3.15 | $-3.60 | $-3.00 | $-4.04 |
| BPA Diluido | $-388.95 | $-164.55 | $-82.50 | $-30.45 | $-29.55 | $-2.70 | $-3.15 | $-3.60 | $-3.00 | $-4.04 |
| Acciones en Circulación (Diluidas) | $16374 | $64985 | $277183 | $566464 | $753902 | $7.8M | $8.4M | $8.4M | $8.4M | $8.6M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.0M | $7.2M | $10.4M | $12.7M | $39.7M | $136.4M | $110.9M | $88.5M | $71.1M | $41.3M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | $358277 | $518097 | $739656 | $634940 | $1.1M | $743000 | 0 | 0 | 0 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | $5.2M | $1.5M | 0 | 0 |
| Activos Corrientes | $3.3M | $7.9M | $11.5M | $14.3M | $42.8M | $141.2M | $118.2M | $92.2M | $74.5M | $45.6M |
| Inmovilizado Material | $55119 | $11467 | $54487 | $84829 | $38685 | $20000 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $640440 | $75686 | $99375 | $68542 | $13375 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $4.1M | $8.2M | $11.7M | $14.5M | $42.8M | $141.3M | $123.5M | $96.3M | $76.4M | $47.6M |
| Cuentas por Pagar | $254320 | $334901 | $353328 | $293171 | $1.6M | $1.7M | $3.0M | $806000 | $679000 | $4.3M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $18053 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $1.0M | $1.2M | $2.9M | $1.3M | $15.7M | $3.1M | $5.6M | $5.2M | $5.0M | $8.3M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $1.0M | $1.2M | $2.9M | $1.3M | $15.7M | $3.1M | $5.6M | $5.2M | $5.0M | $8.3M |
| Reservas | -$57.3M | -$65.4M | -$76.8M | -$94.1M | -$111.9M | -$129.2M | -$156.2M | -$186.3M | -$211.8M | -$246.6M |
| Patrimonio Neto | $3.1M | $6.9M | $8.8M | $13.2M | $27.2M | $138.1M | $118.0M | $91.0M | $71.5M | $39.4M |
| Deuda Total | 0 | 0 | 0 | $50479 | $18053 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$3.0M | -$7.2M | -$10.4M | -$12.6M | -$39.6M | -$136.4M | -$110.9M | -$88.5M | -$71.1M | -$41.3M |
| Capital Circulante | $2.2M | $6.7M | $8.6M | $13.0M | $27.1M | $138.1M | $112.6M | $87.0M | $69.5M | $37.4M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$6.4M | -$8.1M | -$11.4M | -$17.2M | -$17.8M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| Amortizaciones | $303482 | $128994 | $44197 | $52789 | $46520 | $23000 | $8000 | $23000 | $17000 | $16000 |
| Compensación en Acciones | $876189 | $786550 | $2.5M | $8.8M | $3.0M | $5.3M | $6.8M | $4.6M | $2.3M | $2.6M |
| Cambio en Capital Circulante | -$1.1M | -$339887 | -$64405 | -$791297 | -$111352 | -$1.2M | -$599000 | $1.5M | $448000 | $2.3M |
| Flujo de Caja Operativo | -$5.4M | -$6.6M | -$9.0M | -$9.1M | -$11.6M | -$16.5M | -$20.8M | -$20.9M | -$21.0M | -$29.8M |
| Inversiones (CapEx) | -$9213 | 0 | -$110906 | -$7628 | -$9367 | -$9000 | -$27000 | -$14000 | -$19000 | -$23000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -$1.5M | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.4M | -$6.6M | -$9.1M | -$9.1M | -$11.6M | -$16.5M | -$20.8M | -$21.0M | -$21.0M | -$29.8M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Beneficio Neto (anual) | -27.5% | -40.4% | -51.2% | -3.4% | -15.6% | -30.8% | -11.6% | +15.3% | -36.3% | |
| Crecimiento BPA (anual) | +57.7% | +49.9% | +63.1% | +3.0% | +90.9% | -16.7% | -14.3% | +16.7% | -34.7% | |
| Cambio en Acciones (anual) | +296.9% | +326.5% | +104.4% | +33.1% | +934.2% | +8.3% | -0.4% | -0.2% | +2.6% | |
| Crecimiento FCF (anual) | -22.5% | -37.6% | -0.7% | -26.7% | -42.3% | -26.1% | -0.8% | -0.4% | -41.5% | |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | 0.3% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-328.80 | $-101.47 | $-32.73 | $-16.13 | $-15.36 | $-2.11 | $-2.46 | $-2.49 | $-2.51 | $-3.46 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $16374 | $64985 | $277183 | $566464 | $753902 | $7.8M | $8.4M | $8.4M | $8.4M | $8.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -0.65 | -0.28 | -0.19 | -0.77 | -0.48 | -8.89 | -2.52 | -3.67 | -4.72 | -2.19 |
| P/VC | 1.34 | 0.44 | 0.48 | 1.01 | 0.40 | 1.35 | 0.57 | 1.22 | 1.66 | 1.94 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Empresas relacionadas: CGTX · CLNN · COYA · GLSI · IMMX · ONCY · SRZN
Explorar sector: Healthcare · Biotechnology
Más secciones de ATOS: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones